{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T20:59:50Z","timestamp":1725742790861},"publisher-location":"Berlin, Heidelberg","reference-count":29,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783540543350"},{"type":"electronic","value":"9783642956621"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/978-3-642-95662-1_147","type":"book-chapter","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T09:57:36Z","timestamp":1375091856000},"page":"309-318","source":"Crossref","is-referenced-by-count":1,"title":["Mediators and Their Antagonists in Shock Therapy"],"prefix":"10.1007","author":[{"given":"E.","family":"Neugebauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Leuchleuthner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rixen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"147_CR1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/BF02184682","volume":"9","author":"JD Baumgartner","year":"1990","unstructured":"Baumgartner JD (1990) Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock. Eur J Clin Microbiol Infect Dis 9:711\u2013716","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"147_CR2","first-page":"232","volume-title":"Update","author":"CE Hack","year":"1991","unstructured":"Hack CE, Thijs LG (1991) The orchestra of mediators in the pathogenesis of septic shock: A review. In: Vincent JL (ed) Update. Springer, Berlin Heidelberg New York Tokyo, pp 232\u2013246"},{"key":"147_CR3","first-page":"525","volume":"45","author":"K Skarvan","year":"1989","unstructured":"Skarvan K (1989) Mediatoren beim Trauma. Med Welt 45:525\u2013532","journal-title":"Med Welt"},{"key":"147_CR4","first-page":"222","volume-title":"Sepsis \u2014 Eine interdisziplin\u00e4re Herausforderung","author":"E Neugebauer","year":"1988","unstructured":"Neugebauer E, Lorenz W, Schirren J, Dietrich A (1988) Mediatoren in der Pathogenese des septischen Schocks \u2014 Eine Standortbestimmung. In: Reinhart K, Eyrich K (eds) Sepsis \u2014 Eine interdisziplin\u00e4re Herausforderung. Springer, Berlin Heidelberg New York Tokyo, pp 222\u2013236"},{"key":"147_CR5","first-page":"350","volume":"7","author":"LS King","year":"1957","unstructured":"King LS (1957) Dr. Koch\u2019s postulate. J Hist Med Alhed Sci 7:350\u2013361","journal-title":"J Hist Med Alhed Sci"},{"key":"147_CR6","first-page":"470","volume":"58","author":"E Neugebauer","year":"1987","unstructured":"Neugebauer E, Lorenz W, Maroske D, Barthlen W (1987) Mediatoren beim septischen Schock; Strategien zu ihrer Sicherung und zur Einsch\u00e4tzung ihrer kausalen Bedeutung. Chirurg 58:470\u2013481","journal-title":"Chirurg"},{"key":"147_CR7","first-page":"1","volume":"2","author":"E Neugebauer","year":"1987","unstructured":"Neugebauer E, Lorenz W, Maroske D, Barthlen W, Ennis M (1987) The role of mediators in septic\/endotoxic shock. A meta-analysis evaluating the current status of histamine. Theor Surg 2:1\u201328","journal-title":"Theor Surg"},{"key":"147_CR8","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1056\/NEJM198211113072001","volume":"307","author":"EJ Ziegler","year":"1982","unstructured":"Ziegler EJ, McCutchan JA, Fierer J (1982) Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Echerichia coh. N Engl J Med 307:1225\u20131230","journal-title":"N Engl J Med"},{"key":"147_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJM199102143240701","volume":"324","author":"EJ Ziegler","year":"1981","unstructured":"Ziegler EJ, Fischer CJ, Sprung CL (1981) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin \u2014 a randomized, double-blind, placebo-controlled trial. N Engl J Med 324:429\u2013436","journal-title":"N Engl J Med"},{"key":"147_CR10","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.170.4.1409","volume":"170","author":"D Novick","year":"1989","unstructured":"Novick D, Engelmann H, Wallach D, Rubinstein M (1989) So luble cytokine receptors are present in normal human urine. J Exp Med 170:1409\u20131414","journal-title":"J Exp Med"},{"key":"147_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/clinids\/9.Supplement_5.S585","volume":"9","author":"E Neugebauer","year":"1987","unstructured":"Neugebauer E, Lorenz W, Beckurts T, Maroske D, Merte H (1987) Significance of histamine formation and release in the development of endotoxic shock: Proof of current concepts by randomized controlled studies in rats. Rev Infect Dis 9:585\u2013593","journal-title":"Rev Infect Dis"},{"key":"147_CR12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0261-9881(21)00181-6","volume":"2","author":"W Lorenz","year":"1984","unstructured":"Lorenz W, R\u00f6her HD, Doenicke A, Ohmann C (1984) Histamine release in anaesthesia and surgery: a new method to evaluate its chnical significance with several types of causal relationship. Clin Anaesthesiol 2:403\u2013426","journal-title":"Clin Anaesthesiol"},{"key":"147_CR13","first-page":"133","volume":"34","author":"D Rixen","year":"1991","unstructured":"Rixen D, Leuchleuthner A, Saad S, Buschauer A, Nagelschmidt M, Thoma S, Rink A, Neugebauer E (1991) Beneficial effect of H2-Agonism and Hj-Antagonism in endotoxic shock? Circ Shock 34:133","journal-title":"Circ Shock"},{"key":"147_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF01987973","volume":"18","author":"E Neugebauer","year":"1986","unstructured":"Neugebauer E, Beckurts T, Lorenz W, Maroske D, Merte H, Horeyseck G, Dietz W (1986) Induced histidine decarboxylase in endotoxic shock: Identifiaction of the enzyme in rat liver and influence of its inhibitors on survival parameters. Agents Actions 18:23\u201329","journal-title":"Agents Actions"},{"key":"147_CR15","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1172\/JCI112506","volume":"77","author":"JH Stevens","year":"1986","unstructured":"Stevens JH, O\u2019Hanley P, Shapiro JM, Mihm FG, Satoh PS, Collins JA, Raffin TA (1986). Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Chn Invest 77:1812\u20131816","journal-title":"J Chn Invest"},{"key":"147_CR16","volume-title":"Handbook for mediators in septic shock","author":"A Bengtsson","year":"1992","unstructured":"Bengtsson A, Redl H, Heideman M, Schlag G (1992) Complement in septic shock. In: Neugebauer E, Holaday JW (eds) Handbook for mediators in septic shock. CRC Press, (in Vorbereitung)"},{"key":"147_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/275450a0","volume":"275","author":"JW Holaday","year":"1978","unstructured":"Holaday JW, Faden AI (1978) Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 275:450","journal-title":"Nature"},{"key":"147_CR18","first-page":"380","volume":"353","author":"JW Holaday","year":"1989","unstructured":"Holaday JW, Long JB, Martinez-Arizala A, Chenitts A, Reynolds DG, Gurll N (1989) Effects of TRH in circulatory shock and central nervous system ischemia. Ann NY Acad Sci 353:380\u2013389","journal-title":"Ann NY Acad Sci"},{"key":"147_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(81)92865-8","volume":"1","author":"WP Peters","year":"1981","unstructured":"Peters WP, Johnson MW, Friedmann PA (1981) Pressor effect of naloxone in septic shock. Lancet 1:529","journal-title":"Lancet"},{"key":"147_CR20","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/00003246-198308000-00013","volume":"11","author":"JA Groeger","year":"1983","unstructured":"Groeger JA, Carton GC, Howland WS (1983) Naloxane in septic shock. Crit Care Med 11:650","journal-title":"Crit Care Med"},{"key":"147_CR21","first-page":"2319","volume":"35","author":"GS Hughes","year":"1984","unstructured":"Hughes GS (1984) Naloxane and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock Life. Science 35:2319","journal-title":"Science"},{"key":"147_CR22","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(85)91787-8","volume":"1","author":"A DeMaria","year":"1985","unstructured":"DeMaria A, Craven DE, Heffernan JJ (1985) Naloxone versus placebo in treatment of septic shock. Lancet 1:1363\u20131365","journal-title":"Lancet"},{"key":"147_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/archsurg.1990.01410160119023","volume":"125","author":"HR Michie","year":"1990","unstructured":"Michie HR, Wilmore DW (1990) Sepsis, signals and surgical sequelae. Arch Surg 125:531\u2013536","journal-title":"Arch Surg"},{"key":"147_CR24","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/330662a0","volume":"330","author":"KJ Tracey","year":"1987","unstructured":"Tracey KJ, Fong Y, Hesse DG (1987) Anti-cachectin\/TNF antibodies prevent the fatal sequelae of experimental bacteremia in primates. Nature 330:662\u2013664","journal-title":"Nature"},{"key":"147_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/0140-6736(90)91337-A","volume":"1","author":"AR Exley","year":"1990","unstructured":"Exley AR, Cohen J, Buurman W (1990) Monoclonal antibody to TNF in severe septic shock. Lancet 1:1275\u20131276","journal-title":"Lancet"},{"key":"147_CR26","unstructured":"Bernard G, Reines HD, Metz CA, Halushka PV, Swindell SB, Higgins SB, Wright PE, Watts CA (1988) Effects of a short course of Ibuprofen in patients with severe sepsis. AST 138"},{"key":"147_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0165-6147(89)90103-X","volume":"10","author":"P Braquet","year":"1989","unstructured":"Braquet P, Paubert-Braquet M, Koltai H, Bourgain R, Bussolino F, Hosford D (1989) Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol Sci 10:23\u201330","journal-title":"Trends Pharmacol Sci"},{"key":"147_CR28","volume-title":"Handbook of Mediators in Septic Shock","author":"B Gerdin","year":"1992","unstructured":"Gerdin B, Haglund U (1992) Possible Involvment of oxygen free radicals (OFR) in shock and shock related states. In: Neugebauer E, Holaday JW (eds) Handbook of Mediators in Septic Shock., CRC Press (in Vorbereitung)"},{"key":"147_CR29","first-page":"907","volume":"131","author":"E Neugebauer","year":"1989","unstructured":"Neugebauer E, Bouillon B, Dietrich A, Lechleuthner A (1989) Cortison-Standards und neue Tendenzen: Notfallindikation Schock. M\u00fcnch Med Wochenschr 131:907\u2013911","journal-title":"M\u00fcnch Med Wochenschr"}],"container-title":["Deutsche Gesellschaft f\u00fcr Chirurgie","Die Chirurgie und ihre Spezialgebiete Eine Symbiose"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-95662-1_147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T12:27:12Z","timestamp":1646224032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-95662-1_147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"ISBN":["9783540543350","9783642956621"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-95662-1_147","relation":{},"ISSN":["1432-9336"],"issn-type":[{"type":"print","value":"1432-9336"}],"subject":[],"published":{"date-parts":[[1991]]}}}